147 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
ARRY Array BioPharma Inc. $14.1 $2.97B N/A
Article Searches
Own Altria For The Dividend - Cramer's Lightning Round (9/20/17) https://seekingalpha.com/article/4108484-altria-dividend-cramers-lightning-round-9-20-17?source=feed_all_articles Sep 21, 2017 - Book partial profits on STMicroelectronics.Intercept Pharmaceuticals is a speculative biotech with positive news.Array BioPharma has the money to expand its portfolio.
Your Daily Pharma Scoop: ACADIA's Growth Potential, Lexicon's Diabetes Troubles, Neos Down Post-Approval https://seekingalpha.com/article/4107662-daily-pharma-scoop-acadias-growth-potential-lexicons-diabetes-troubles-neos-post-approval?source=feed_tag_editors_picks Sep 18, 2017 - The Weekly Pharma Scoop has become daily as of today.ACADIA's growth potential in PDP and also in ADP is discussed.Lexicon's slump following positive data and its interpretation by a Seeking Alpha con
Altice sets deal with Arris for next-gen set-tops https://seekingalpha.com/news/3295868-altice-sets-deal-arris-next-gen-set-tops?source=feed_news_all Sep 15, 2017 - Altice (OTCPK:ATCEY) is expanding its deal with Arris (ARRS +0.6%) to enable a multinational deployment of new 4K HDR set-top boxes starting in 2018. Altice-owned Portugal Telecom had selected Arris
Colorado biotech plans $200 million stock offering http://feeds.bizjournals.com/~r/industry_6/~3/sS3ftO8r3SA/colorado-biotech-plans-200-million-stock-offering.html Sep 14, 2017 - A Boulder biotech said it's commenced an underwritten public offering of about $200 million of its stock. Array BioPharma Inc. said it's begun an offering of $175 million of shares of its common stock, and it's giving underwriters the option to buy up to an additional $26 million in shares. "We intend to use the net proceeds from this offering to fund our research and development efforts, including clinical trials for our proprietary candidates, build and scale commercial capability, and for general…
Steven Cohen Dives Into Array BioPharma http://www.gurufocus.com/news/565707/steven-cohen-dives-into-array-biopharma Sep 13, 2017 - Steven Cohen Dives Into Array BioPharma, Stocks: ARRY,PCRX,AKAO,BIIB,JNJ, Steven Cohen, release date:Sep 13, 2017
Your Weekly Pharma Scoop: Valeant's CRL Resolution, Eagle Undervalued, Array Positive Results https://seekingalpha.com/article/4105883-weekly-pharma-scoop-valeants-crl-resolution-eagle-undervalued-array-positive-results?source=feed_tag_editors_picks Sep 11, 2017 - This is the once-weekly Pharma scoop published by the Total Pharma Tracker.In today's analysis, Valeant's CRL issue may be resolved soon.Array Biopharma showed positive results in phase 3 trials.
Array BioPharma And Others Shine At The ESMO 2017 Congress http://feeds.benzinga.com/~r/benzinga/~3/fTqGOv1j2h8/array-biopharma-and-others-shine-at-the-esmo-2017-congr Sep 11, 2017 -

The 2017 ESMO Congress wraps up on Tuesday in Madrid, Spain. On Monday, Jefferies issued a handful of flash notes related to companies presenting at the conference.

Here’s a breakdown of the highlights.

ARRY: Stifel reits Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20170911064358 Sep 11, 2017 - Stifel issues rating change for ARRY
Trading halted Array BioPharma pending news; shares up 5% https://seekingalpha.com/news/3294453-trading-halted-array-biopharma-pending-news-shares-5-percent?source=feed_news_all Sep 08, 2017 - Nasdaq has suspended trading in Array BioPharma (ARRY +5.1%) pending the release of news.
What's Behind Array Biopharma Inc.'s 31% Rally in August? https://www.fool.com/investing/2017/09/06/why-array-biopharma-inc-stock-swelled-31-in-august.aspx?source=iedfolrf0000001 Sep 06, 2017 - The company's lead candidates took another step forward last month.

Pages: 1...56789101112131415

<<<Page 10>